Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NCK2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | SNX25 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | CCNA2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | SLC30A1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | PLXNB1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | CD46 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | RNF115 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | ELP5 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | HUWE1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | CKAP5 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |